Back to search

Article

Urinary Biomarkers in Urothelial Carcinoma: Expanded Con-temporary Evidence for Diagnosis, Surveillance, Risk Stratification, and Cystoscopy-Sparing Clinical Pathways

2026-05-26

Abstract excerpt

<h4>Background: </h4> /Objectives:Urothelial carcinoma remains one of the most surveillance-intensive malignancies in urologic oncology because, particularly in the non-muscle-invasive setting, it combines prolonged survivorship with frequent recurrence and the need for repeated cystoscopic reassessment. Conventional follow-up based on cystos-copy and urinary cytology is clinically entrenched but limited by invasi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
df334428-9053-511b-ae63-3a527623d2ad
DOI
10.20944/preprints202605.1807.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Urinary Biomarkers in Urothelial Carcinoma: Expanded Con-temporary Evidence for Diagnosis, Surveillance, Risk Stratification, and Cystoscopy-Sparing Clinical PathwaysDOI 10.20944/preprints202605.1807.v1
Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity
Uromonitor®: Clinical Validation and Performance Assessment of a Urinary Biomarker for Recurrence Surveillance in Non-Muscle Invasive Bladder Cancer PatientsSemantic proximity
Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence.Semantic proximity
Roles for epigenetic and other biomarkers in upper tract urothelial carcinoma diagnosis and surveillanceSemantic proximity
Diagnostic Test Accuracy of Commercially Available Tests for The Recurrence of Bladder Cancer: A Systematic Review and Meta-AnalysisSemantic proximity
GALEAS™ Bladder Demonstrates High Sensitivity and Specificity for Detecting Bladder Cancer: Real-World Multicentre Data from UK NHS Haematuria ClinicsSemantic proximity
Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?Semantic proximity
DNA Methylation Urine Biomarkers Test in the Diagnosis of Upper Tract Urothelial Carcinoma: Results from a Single-Center Prospective Clinical TrialSemantic proximity
Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAsSemantic proximity
Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current DevelopmentSemantic proximity
A systematic review on diagnostic and prognostic biomarkers for bladder cancerSemantic proximity
From feasibility to clinical pathways: a bibliometric and knowledge-mapping analysis of urine-based liquid biopsy in urologic cancers (2015–2025)Semantic proximity
Select a neighboring publication to make it the new centre.